this form of selective reporting, it is recommended that both primary ST rates (without
intercurrent target lesion revascularization) and secondary ST rates (with intercurrent target …

follows activation of the enzyme phospholipase A2. On release, arachidonic acid is rapidly
metabolized by prostaglandin (PG) H2 synthase, also known as cyclooxygenase (COX) …

Objectives: The purpose of this study was to investigate the long-term safety and efficacy of
percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation for …

Objectives: We aimed to evaluate the risk of definite stent thrombosis with bare-metal stents
(BMS) and drug-eluting stents (DES) in patients treated for acute coronary syndromes …

The management of patients with coronary artery stents during the perioperative period is
one of the most important patient safety issues clinicians confront. Perioperative stent …

Aims Long-term benefit from coronary revascularization with drug-eluting stents (DES)
relative to bare metal stents (BMS) and coronary artery bypass grafting (CABG) has not been …

Thrombosis of a drug-eluting stent (DES) is a catastrophic complication. The risk of stent
thrombosis (ST) is increased in the perioperative setting and is strongly associated with the …

Background—Drug eluting stents prevent vascular restenosis but can delay endothelial
healing. A rabbit femoral artery model of stenosis formation after vascular injury was used to …

The subspecialty of interventional cardiology has made significant progress in the
management of coronary artery disease over the past three decades with the development …

Implantation of drug-eluting stents (DESs) via percutaneous coronary intervention is the
most popular treatment option to restore blood flow to occluded vasculature. The many …